] . (2014). Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults. Vaccine, 32(47), 6284-93. presented at the 2014 Oct 29. doi:10.1016/j.vaccine.2014.08.076
. (2014). Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals.. Vaccine, 32(23), 2732-9. presented at the 2014 May 13. doi:10.1016/j.vaccine.2014.02.043
. (2014). Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA, 311(17), 1760-9. presented at the 2014 May 07. doi:10.1001/jama.2014.3633
. (2015). Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.. Vaccine, 33(39), 5225-34. presented at the 2015 Sep 22. doi:10.1016/j.vaccine.2015.06.075
. (2016). Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine. Vaccine, 34(4), 547-554. presented at the 2016 Jan 20. doi:10.1016/j.vaccine.2015.11.055
. (2016). Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination. J Infect Dis, 214(7), 1020-9. presented at the 2016 10 01. doi:10.1093/infdis/jiw310
. (2017). Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial. PLoS One, 12(1), e0167488. presented at the 2017. doi:10.1371/journal.pone.0167488
. (2017). Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections. J Virol, 91(23). presented at the 2017 12 01. doi:10.1128/JVI.00942-17
. (2017). Proteomics show antigen presentation processes in human immune cells after AS03-H5N1 vaccination. Proteomics, 17(12). presented at the 2017 Jun. doi:10.1002/pmic.201600453
. (2017). RSEQREP: RNA-Seq Reports, an open-source cloud-enabled framework for reproducible RNA-Seq data processing, analysis, and result reporting. F1000Res, 6, 2162. presented at the 2017. doi:10.12688/f1000research.13049.2
. (2017). Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial. Vaccine, 35(13), 1675-1682. presented at the 2017 03 23. doi:10.1016/j.vaccine.2017.02.032
. (2017). Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial. Vaccine, 35(36), 4730-4737. presented at the 2017 08 24. doi:10.1016/j.vaccine.2017.07.024
. (2019). AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells. J Infect Dis, 219(11), 1786-1798. presented at the 2019 05 05. doi:10.1093/infdis/jiy721
. (2019). Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses. Vaccines (Basel), 8(1). presented at the 2019 Dec 24. doi:10.3390/vaccines8010004
. (2020). Cytomegalovirus Genetic Diversity Following Primary Infection. J Infect Dis, 221(5), 715-720. presented at the 2020 Feb 18. doi:10.1093/infdis/jiz507
. (2020). Flagellin adjuvanted F1/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signatures. NPJ Vaccines, 5, 6. presented at the 2020. doi:10.1038/s41541-020-0156-y
. (2020). Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine. Vaccines (Basel), 8(1). presented at the 2020 Feb 06. doi:10.3390/vaccines8010069